Professor Seth Grant
Professor of Molecular Neuroscience
- Centre for Clinical Brain Sciences
- G2C::Genes to Cognition
- Edinburgh Neuroscience
Contact details
- Tel: +44 (0)131 242 7984
- Email: seth.grant@ed.ac.uk
Address
- Street
-
Chancellor's Building
Edinburgh BioQuarter
49 Little France Crescent - City
- Edinburgh
- Post code
- EH16 4SB
Background
- 1980/1984, Graduated from Sydney University with a Bachelor of Science (Medicine) in Physiology, Bachelor of Medicine and Bachelor of Surgery
- 1985-1989, Postdoctoral Fellow at Cold Spring Harbor Laboratory with Douglas Hanahan
- 1989-1994, Postdoctoral Fellow with Eric Kandel at Columbia University
- 1994, Centre for Genome Research at Edinburgh University
- 2000, Professor of Molecular Neuroscience, Edinburgh University
- 2003, Principal Investigator at the Wellcome Trust Sanger Institute in Cambridge
- 2011, Professor of Molecular Neuroscience , University of Edinburgh
- Additional appointments: John Cade Visiting Professor at Melbourne University, Honorary Professorship at Cambridge University
-
Awards: Kenneth B. Myer Award (2014), Wesley College Foundation Medal (2017), IBANGS Distinguished Investigator Award (2019), FENS EJN Award (2020)
Qualifications
BSc(Med), MB, BS, FRSE, FMedSci, MAE
Responsibilities & affiliations
Fellow of the Royal Society of Edinburgh
Fellow of the Academy of Medical Sciences
Member of Academia Europaea
Associate Member of UKDRI
Editorial board of five journals, including Neuroscience
Founder and Director of the Genes to Cognition Programme
Undergraduate teaching
Neuroscience 3
Postgraduate teaching
MSc by Research in Integrative Neuroscience
Open to PhD supervision enquiries?
Yes
Research summary
Our long-term goal is to understand the fundamental mechanisms of behaviour. We study the genes and proteins that control synapses – the connections between nerve cells. Multiprotein machines comprising many different synapse proteins are responsible for innate and learned behaviours, and their dysfunction underlies many brain diseases and neurological conditions, including Alzheimer’s disease, schizophrenia, autism, depression, addiction and intellectual disability. These mechanisms are conserved between mice and humans, opening new avenues for diagnosis and therapeutic discoveries.
Current research interests
Our current research is focussed on uncovering the scope and functional impacts of synapse diversity throughout the brain. We have developed methods for brain-wide mapping of protein composition at single-synapse resolution. These ‘synaptome’ maps, which reveal the molecular and morphological features of a billion synapses, have uncovered unprecedented spatiotemporal synapse diversity organised into an architecture that correlates with the structural and functional connectomes. We have characterised how the synaptome architecture of the brain changes throughout the lifespan, with phases of rapid expansion followed by slow decline in old age that may inform on natural ageing and windows of disease susceptibility. Importantly, we have shown that mutations that cause cognitive disorders such as autism reorganise synaptome maps.
These new findings on synapse diversity have important implications for brain function in terms of learning and memory, leading to new models of how information is stored and recalled. We are now investigating the dynamics of the synaptome – the extent to which synapses change in the short term, during daily sleep cycles, and how rapidly synapse proteins are replaced; and, in the longer term, how sensory inputs from the environment and activity-dependent behaviour influence synaptome development. We are also unlocking brain complexity by characterising synapse diversity in the fundamental unit of the brain – the individual neuron. A major effort is progressing our laboratory, image analysis and computational tools to the direct study of the human brain, revealing the progressive impacts on the synaptome of dysfunctions such as Alzheimer’s disease, schizophrenia and ALS-FTD. Synaptome mapping also has the potential to complement clinical techniques, uncovering what diagnostic imaging approaches such as PET tell us about damage to the synaptome. A key aim going forwards is to integrate all these synaptome data within existing large-scale international brain data resources to maximize their health discovery value.
Research group members
- Noboru Komiyama: Senior Lecturer
- Emily Robson: Lab Manager
- Digin Dominic: Informatics Engineer
- Colin Yuan: Postdoctoral Image Analysis Developer
-
Jessica Griffiths: Postdoctoral Researcher
-
Takeshi Kaizuka: Postdoctoral Researcher
- Edita Bulovaite: Postdoctoral Researcher
- Hanan Woods: Postdoctoral Researcher
- Wu Ying: Postdoctoral Researcher (Visiting Scholar)
-
Wen Chyi Quah: PhD Student
-
Aisha Belhadi: PhD Student
-
Candace Adams: PhD Student (co-supervised)
- Gabor Varga: Research Assistant
- Bev Notman: Research Assistant
- Sarah Catherine Gillard: Research Technician
- Ülkü Günar: Research Technician
- Vilhelmiina Savolainen: Research Technician
Sources of funding
The Grant lab is funded by the Wellcome Trust, European Research Council, Medical Research Council, Simons Initiative for the Developing Brain, Chan Zuckerberg Initiative, and Medical Research Scotland.
Affiliated research centres
More video
- Synapse proteins and the lifespan (Brain Science Podcast 211)
- The lifespan synaptome atlas of the mouse brain
- Synapse complexity (Brain Science Podcast 176)
- Explore the synaptome (Brain Science Podcast 150)
- Genetic lifespan calendar (Brain Science Podcast 137)
- In Conversation with ERC Grantee and Australian Neuroscientist Prof Seth Grant (EURAXESS Australia & New Zealand, 10 May 2020)
- Searching for the molecular building blocks of behaviour (IBANGS Distinguished Investigator Award Lecture, 13 May 2019)
Read more about CCBS research into synaptic biology & disease
Read more about CCBS basic lab science research
The Genes to Cognition research website and database
The Genes to Cognition education website
Mouse Lifespan Synaptome Atlas
Protein Lifetime Synaptome Atlas
Pax6 Developmental Synaptome Atlas